cerrar
Tagged with

PMDA Chief Executive Yasuhiro Fujiwara on Regulatory Utilisation…
Writing in the October edition of DIA’s Global Forum magazine, Chief Executive of Japan’s Pharmaceuticals and Medical Devices Agency (PMDA)…

Boehringer Ingelheim Announces Contract Manufacturing Partnership…
Boehringer Ingelheim (BI), the largest private pharma company in the world, has become the latest Big Pharma player to commit to Turkish localization…

China Pharma News: BMS/BeiGene Spat Intensifies; US Senators Call…
The latest news from Chinese pharma and biotech, including BMS’ attempts to pull out of its Abraxane supply deal with local player BeiGene; a…

Saudi Arabia’s Vision 2030 Healthcare Transformation…
Saudi Arabia’s ambitious Vision 2030 economic transformation plan aims at transitioning the Middle East’s largest economy away from an…

Asbjørn Overgaard – CEO/Managing Director, Copenhagen…
Copenhagen Capacity is Greater Copenhagen's official organization for investment, promotion, and business development. Its CEO/managing director,…

Peter Drøidal – Country Manager Denmark & Nordic Head…
Danish pharma industry veteran Peter Drøidal highlights how he steered the Danish Novartis affiliate through the COVID-19 pandemic period, the…

Peter Huntley – Managing Director, Medtech Denmark…
Peter Huntley of Medicoindustrien, the industry association for Danish medtech, outlines his vision for the industry, including why a shift to broad,…

Ahmed Aljedai – Assistant Deputy Minister of Therapeutic…
Prof. Ahmed Aljedai, assistant deputy minister of therapeutic affairs for support services at Saudi Arabia’s Ministry of Health (MoH) outlines how…

Gözde Güllüoğlu – General Manager Turkey Cluster,…
After being present in the Turkish market for more than 28 years, MSD seems confident that it will be able to seize upcoming opportunities due to the…

WHO Gives Go-Ahead for First Ever Malaria Vaccine
In a notable first, following successful pilot immunisation programmes in Ghana, Kenya and Malawi, the World Health Organization (WHO) has recommended…

India Pharma News: Piramal Demerges Pharma Business; Lundbeck…
The latest news from Indian pharm and healthcare, including Piramal Enterprises’ decision to demerge and list its pharma arm, the country’s 15…

Carlo Toniatti – CSO, IRBM
Carlo Toniatti, chief scientific officer of IRBM, gives his insights into how the increased participation of early-stage ventures in the drug R&D…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here